Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
Hims Halts Compounded GLP-1 Pill as FDA Cracks Down, Molina Plunges on Profit Warning
Hims & Hers discontinues its $49 compounded semaglutide offering following FDA enforcement signals, sending shares down 16%. Molina Healthcare forecasts 2026 profit far below expectations, triggering a 28% stock drop.
Netflix Faces DOJ Antitrust Scrutiny Over Warner Bid Ahead of Key Market Data
Netflix shares edged lower after hours as the Justice Department examines potential anti-competitive conduct in its $82.7 billion Warner Bros Discovery acquisition. The streamer says it is unaware of any probe beyond standard merger review.
FDA Crackdown on Compounded Weight-Loss Drugs Boosts Eli Lilly Shares
Eli Lilly's stock rose 3.7% after the FDA warned Hims & Hers to halt sales of a non-approved compounded GLP-1 weight-loss pill, signaling a regulatory clampdown that may support pricing for branded obesity drugs.
GSK Gains EU Approval for Nucala in COPD, Stock Momentum in Focus
GSK shares rose after EU regulators approved expanded use of Nucala for chronic obstructive pulmonary disease. The stock has surged 17% this week and nearly 49% over the past year.
Huntington Bank Appoints Former BNY Risk Chief as CRO Amid Regulatory Shift
Huntington Bank has named Senthil Kumar, previously the top risk officer at BNY, as its new chief risk officer. The move follows the bank's entry into a stricter regulatory category after its merger with Cadence Bank pushed assets to $279 billion.
Abbott Faces Regulatory Scrutiny on Libre Sensors as Insider Buying and New AFib Data Emerge
Abbott shares rose 1.6% to $110.83 Friday but remain 21.5% below their 52-week high. The FDA updated a Class I recall for FreeStyle Libre 3 sensors, citing 860 serious injuries and seven deaths, while an insider purchased 10,000 shares.
Novo Nordisk Shares Rebound as Hims Halts Wegovy Copycat After FDA Pressure
Novo Nordisk's Class B shares surged 5.3% after Hims & Hers discontinued its compounded Wegovy pill following U.S. regulatory warnings. The stock had dropped nearly 8% when the copycat launched.
Shell Announces Auditor Switch, Kazakhstan Investment Pause Amid Ongoing Buybacks
Shell has selected PwC as its new auditor starting in 2027 and will halt new investments in Kazakhstan due to legal disputes. The company continues its share repurchase program.
IHC Issues Phishing Alert as Shares Hold Steady Near 400 Dirhams
International Holding Company warns investors of fraudulent emails using its branding, while its stock trades flat at 399.60 dirhams. UAE equities edged higher amid focus on geopolitics and oil.
Netflix Gains as DOJ Expands Warner Deal Scrutiny; Hastings Files Share Transfer
Netflix shares closed 1.6% higher at $82.20 amid a deepening Justice Department antitrust review of its $82.7 billion Warner Bros Discovery acquisition. Director Reed Hastings reported transferring 241,944 shares via a family trust.